Subsequent studies have identified tubularly secreted NGAL as a novel and specific biomarker for the early detection of AKI in several settings including cardiac surgery [8,9], contrast agent administration [10,11], unselected patients in the emergency department [12] and in critically ill patients [13-15]. The gene discussed is LCN2; the disease is acute kidney injury.